ÂÜÀòÂÒÂ×

Dr. Michael Mizhiritzkii is an innovative specialist in medicinal-chemistry with a strong record of developing quality drug candidates and lead compounds. He has led or collaborated on projects through all phases of drug discovery and specializes in guidance on tactics of individual projects from target selection and hit identification, through hit-to-lead, lead optimization and early clinical studies. Dr. Mizhiritzkii holds a PhD in organic chemistry from Leningrad Technological Institute and has worked in the biotech industry for over two decades.

Since 2007, Dr. Mizhiritzkii has worked as an independent consultant in organic, bio-organic and medicinal-chemistry and CMC advisor. He has collaborated on over 100 projects in the pharma, agrochemical, green chemistry and biotechnology sectors, with companies such as Heparx, Lutris Pharma, Reltar Therapeutics, M.G. Therapeutics, Galmed, Paz Oil Company, Makhteshim Chemical Works, Agan Chemical Manufactures, Perrigo, Chemagis, IMI TAMI Institute for Research and Development Ltd, MIGAL – Galilee Technology Center, Haifa Chemicals as well as several start-ups.

Dr. Mizhiritzkii joined Omnix in 2018 and advises on solutions and strategy for multi-step organic synthesis in light of economical parameters. He is critical to the intermediate production and custom synthesis of peptide API, as well as to process development and production from laboratory to industrial scale.